Haoxi Health Technology (HAO) Common Equity (2023 - 2025)

Haoxi Health Technology's Common Equity history runs 3 years deep, the most recent figure standing at $17.4 million for Q2 2025.

• In Q2 2025, Common Equity rose 54.16% year-over-year to $17.4 million; the TTM figure through Jun 2025 stood at $17.4 million (up 54.16% YoY), while the FY2025 annual figure was $17.4 million, up 54.16% from the prior year.
• Common Equity was $17.4 million for Q2 2025 at Haoxi Health Technology, up from $11.3 million in the prior quarter.
• In the past five years, Common Equity ranged from a high of $17.4 million in Q2 2025 to a low of $1.6 million in Q2 2023.
• Historically, Common Equity has averaged $10.1 million across 3 years, with a median of $11.3 million in 2024.
• The sharpest annual moves came in 2024 and 2025: Common Equity surged 619.56% in 2024, then jumped 54.16% in 2025.
• A 3-year view of Common Equity shows it stood at $1.6 million in 2023, then soared by 619.56% to $11.3 million in 2024, then surged by 54.16% to $17.4 million in 2025.
• The last three Common Equity figures came in at $17.4 million (Q2 2025), $11.3 million (Q2 2024), and $1.6 million (Q2 2023), per Business Quant data.